Patent · US Active

Composition comprising botulinum toxin

US11969461B2 · kind B2 · utility

0Cited by

17References

13Claims

0Family size

Assignee

Merz Pharma GmbH & Co. KGaA · DE

Inventors

Klaus Fink · Cologne, DE
Harold Victor Taylor · Frankfurt am Main, DE
Hermann Russ · Mittlisberg, CH
Peter Boderke · Schwalbach, DE

Key dates

Filing date	Feb 28, 2017
Grant date	Apr 30, 2024
Priority date	—
Expiry date	Apr 20, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention concerns a composition comprising (a) botulinum toxin and (b) non-crosslinked hyaluronic acid and its use of the treatment or prevention of dystonia, spasticity and/or wrinkles. Further, the present invention relates to a method for cosmetically smoothing or preventing wrinkles comprising the step of administering the present composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.